ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Raub Briefs Councils On Women’s Health, Cost Containment

October 12, 1990

Ominous Note: Magnuson Hints Senate May Cut NCI Budget 5% Under President’s 1980 Request

March 9, 1979

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996